SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 2.200+5.3%10:49 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: coyote who wrote (496)11/10/1998 10:58:00 PM
From: Anthony Wong  Read Replies (2) of 2539
 
coyote, with Pfizer as Monsanto's marketing partner, there is a very good chance of Celebrex getting a bigger market share. See what they've done with WLA's Lipitor, the cholesterol drug. Lipitor's market share grew to 41.8% versus 41.4% a week ago, and in Sept. they only have 36% market share; the product (despite Merck's best efforts) continues to gain ground. Now Merck is offering a 30 days money-back guarantee which I don't think would help much. I agree with you that the twice-a-day versus once-a-day isn't a big deal.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext